Clinical Trial Update: Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

View source ↗

Summary

This clinical trial update assesses the safety and effectiveness of low-dose edoxaban in patients with nonvalvular atrial fibrillation. The sponsor is Samsung M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Samsung Medical Center | Conditions: Atrial Fibrillation | Status: UNKNOWN